ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$37.850-0.750 (-1.943%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$38.600

Kõrge

$39.310

Madal

$37.770

Maht

1.40M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

5.2B

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

2.39M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $9.57Praegune $37.850Kõrge $43.69

Seotud uudised

BusinessWire

Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming events: American Heart Association (AHA) Scientific Sessions 2025 – November 7-10,

Vaata rohkem
Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences
BusinessWire

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that as an inducement to entering into employment with the Company, on October 24, 2025, the Company's Board of Directors approved "inducement" grants to 84

Vaata rohkem
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BusinessWire

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that a global licensing and collaboration agreement with Novartis, previously announced on September 2, 2025, has now closed. Closing of the transaction was

Vaata rohkem
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis